AustralaSian COVID-19 trial opens in India
One new treatment that’s recently been added to ASCOT is nafamostat
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon Biologics and Viatris get CHMP Nod for Abevmy
Bevacizumab inhibits the formation of tumor vasculature, thereby inhibiting tumor growth
US gives EUA J&J’s COVID-19 vaccine
In J&J’s 44,000-person global trial, the vaccine was found to be 66 per cent effective at preventing moderate-to-severe…
Hoarding of COVID-19 vaccines are threatening global supply via COVAX: WHO
WHO is one of the leaders of COVAX, a programme that aims to supply 1.3 billion vaccine doses to poor and middle income countries…
Sales of injectable anti-HIV therapeutics will reach $2 billion in 2029: GlobalData
Cabotegravir-based therapies are projected to generate 79 per cent of the sales of injectable therapeutics in the HIV market in…
PHARMAP 2021to be held in Berlin
To be held on June 28-29, 202, Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) will focus on how Pharma 4.0…
Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN
It has signed an agreement for the delivery of COVAXIN during Q2 and Q3 2021
NATCO launches Brivaracetam tablets in India
Brivaracetam is indicated towards treatment of epilepsy.
Amneal gets USFDA approval for Norelgestromin and Ethinyl Estradiol Transdermal System
The company granted 180 days of exclusivity under FDA Competitive Generic Therapy (CGT) approval pathway
Researchers at Strathclyde University study effect of Favipiravir against mild COVID-19 infections
It must be taken within four days of a positive swab test and researchers will assess the effectiveness of the drug to help with…